Tularemia

Clinical Microbiology Reviews

Volumn 15, Issue 4, 2002, Pages 631-646

  Ellis, Jill ^a   Oyston, Petra C F ^a   Green, Michael ^a   Titball, Richard W ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; DRINKING WATER; GENTAMICIN; KETOLIDE; LEVOFLOXACIN; TELITHROMYCIN; TETRACYCLINE; BACTERIAL VACCINE;

AQUATIC ENVIRONMENT; BACTERICIDAL ACTIVITY; CHLAMYDIA; CHLORINATION; EPIZOOTIOLOGY; FRANCISELLA TULARENSIS; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; LEGIONELLA; MAMMAL; NONHUMAN; REVIEW; TULAREMIA; ANIMAL; CLASSIFICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIRULENCE;

CHLAMYDIA; FRANCISELLA TULARENSIS; LEGIONELLA; MAMMALIA;

ANIMALS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; FRANCISELLA TULARENSIS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; TULAREMIA; VIRULENCE;

EID: 0036780908     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.15.4.631-646.2002     Document Type: Review

References (185)

1. Abshire, K. Z., and F. C. Neidhardt. 1993. Analysis of protein synthesised by Salmonella typhimurium during growth within a host macrophage. J. Bacteriol. 175:3734-3743.
2. Aikimbaev, M. A. 1966. Taxonomy of genus Francisella. Rep. Acad. Sci. Kaz. SSR Ser. Biol. 5:42-44.
3. Ancuta, P., T. Pedron, R. Girard, G. Sandstrom, and R. Chaby. 1996. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64:2041-2046.
4. Anonymous. 2000. Tularemia, Kosovo. Wkly. Epidemiol. Rec. 75:133-134.
5. Anonymous. 2001. Basic laboratory protocols for the presumptive identification of Francisella tularensis. Centers for Disease Control and Prevention, Atlanta, Ga.
6. Anthony, L. S. D., E. Skamene, and P. A. L. Kongshaven. 1988. Influence of genetic background on host resistance to experimental murine tularemia. Infect. Immun. 56:2089-2093.
7. Anthony, L. S. D., R. D. Burke, and F. E. Nano. 1991. Growth of Francisella spp. in rodent macrophages. Infect. Immun. 59:3291-3296.
8. Anthony, L. S. D., M. Gu, S. C. Cowley, W. W. S. Leung, and F. E. Nano. 1991. Transformation and allelic replacement in Francisella spp. J. Gen. Microbiol. 137:2697-2703.
9. Anthony, L. S. D., P. J. Morrisey, and F. E. Nano. 1992. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148:1829-1832.
10. Anthony, L. S. D., S. C. Cowley, K. E. Mdluli, and F. E. Nano. 1994. Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: correlation with the loss of MinD homologue expression. FEMS Microbiol. Lett. 124:157-166.
11. Bachiller Luque, P., J. L. Perez Castrillon, M. Martin Luquero, F. J. Mena Martin, J. de la Lama Lopez-Areal, P. Perez Pascual, M. A. Mazon, and V. Herreros Guilarte. 1998. Preliminary report of an epidemic tularemia outbreak in Valladolid. Rev. Clin. Esp. 198:789-793.
12. Baker, C. N., D. G. Hollis, and C. Thornsberry. 1985. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J. Clin. Microbiol. 22:212-215.
13. Baron, G. S., and F. E. Nano. 1998. MglA and MglB are required for the intramacrophage growth of Francisella novicida. Mol. Microbiol. 29:247-259.
14. Bell, J. F. 1977. Tularemia-a review. CRC Handbook Series in Zoonoses, Section A, p. 161. CRC Press, Boca Raton, Fla.
15. Berdal, B. P., R. Mehl, N. K. Meidell, A.-M. Lorentzen-Styr, and O. Scheel. 1996. Field investigations of tularemia in Norway. FEMS Immunol. Med. Microbiol. 13:191-195.
16. Berdal, B. P., R. Mehl, H. Haaheim, M. Loksa, R. Grunow, J. Burans, C. Morgan, and H. Meyer. 2000. Field detection of Francisella tularensis. Scand. J. Infect. Dis. 32:287-291.
17. Boyce, J. M. 1975. Recent trends in the epidemiology of tularemia in the United States. J. Infect. Dis. 131:197-199.
18. Brown, S. L., F. T. McKinney, G. C. Klein, and W. L. Jones. 1980. Evaluation of a safranin-O-stained antigen microagglutination test for Francisella tularensis antibodies. J. Clin. Microbiol. 11:146-148.
19. Buddingh, G. J., F. C. Womack. 1941. Observations on the infection of chick embryos with Bacterium tularense, Brucella, and Pasteurella pestis. J. Exp. Med. 74:213-222.
20. Burke, D. S. 1977. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J. Infect. Dis. 135:55-60.
21. Carlsson, H. E., A. A. Lindberg, G. Lindberg, B. Hederstedt, K. A. Karlsson, and B. O. Agell. 1979. Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia. J. Clin. Microbiol. 10:615-621.
22. Chamberlain, R. E. 1965. Evaluation of a live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
23. Clarridge, J. E. I., T. J. Raich, A. Sjostedt, G. Sandstrom, R. O. Darouiche, R. M. Shawar, P. R. Georghiou, C. Osting, and L. Vo. 1996. Characterization of two unusual clinically significant Francisella strains. J. Clin. Microbiol. 34:1995-2000.
24. Conlan, J. W., and R. J. North. 1992. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun. 60:5164-5171.
25. + T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect. Immun. 62:5603-5607.
26. Conley, J., H. M. Yang, T. Wilson, K. Blasetli, V. DiNinno, G. Schnell, and J. P. Wong. 1997. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice. Antimicrob. Agents Chemother. 41:1288-1292.
27. Coriell, L. L, E. O. King, and M. G. Smith. 1948. Studies on tularemia IV. Observations on tularemia in control and vaccinated monkeys. J. Immunol. 58:183-202.
28. Councilman, W. T., and R. P. Strong. 1921. Plague-like infections in rodents. Trans. Assoc. Am. Physicians 36:135-143.
29. Cowley, S. C., S. V. Mjltseva, and F. E. Nano. 1996. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20:867-874.
30. Cross, J. T., and R. F. Jacobs. 1993. Tularemia -treatment failures with outpatient use of ceftriaxone. Clin. Infect. Dis. 17:976-980.
31. Dennis, D. T., T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, M. Layton, S. R. Lillibridge, J. E. McDade, M. T. Osterholm, T. O'Toole, G. Parker, A. M. Perl, P. K. Russell, and K. Tonat. 2001. Tularemia as a biological weapon-medical and public health management. JAMA 285:2763-2773.
32. D'iakov, S. I., V. P. Bubnov, I. K. Lebedeva, S. V. Sidorenko, and V. I. Moskalenko. 2000. The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation model infecting white mice with tularemia. Antibiot. Khimioter. 45:17-20.
33. Doern, G. V. 2000. Detection of selected fastidious bacteria. Clin. Infect. Dis. 30:165-173.
34. Dolan, S. A., C. B. Dommaraju, and G. B. DeGuzman. 1998. Detection of Francisella tularensis in clinical specimens by use of polymerase chain reaction. Clin. Infect. Dis. 26:764-765.
35. Dorofe'ev, K. A. 1947. Classification of the causative agent of tularemia. Symp. Res. Works Inst. Epidemiol. Mikrobiol. Chita. 1:170-180.
36. Eigelsbach, H. T., and C. M. Downs. 1961. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J. Immunol. 87:415-425.
37. Eigelsbach, H. T., and J. J. Tulis. 1961. Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine. Proc. Soc. Exp. Biol. Med. 108:732-734.
38. Eigelsbach, H. T., J. J. Tulis, M. H. McGavran, and J. D. White. 1962. Live tularemia vaccine. I. Host-parasite relationship in monkeys vaccinated intracutaneously or aerogenically. J. Bacteriol. 84:1020-1027.
39. Eigelsbach, H. T., R. B. Hornick, and J. J. Tulis. 1967. Recent studies on live tularemia vaccine. Med. Ann. Dist. Columbia 36:282-286.
40. AL. p. 394-399. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams and Wilkins Co., Baltimore, Md.
41. Elkins, K. L., T. Rhinehart-Jones, C. A. Nacy, R. K. Winegar, and A. H. Fortier. 1993. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61:823-829.
42. Elkins, K. L., T. R. Rhinehart-Jones, S. J. Culkin, D. Yee, and R. K. Winegar. 1996. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect. Immun. 64:3288-3293.
43. Reference deleted.
44. Enderlin, G., L. Morales, R. F. Jacobs, and J. T. Cross. 1994. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin. Infect. Dis. 19:42-47.
45. Ericsson, M., A. Tarnvik, K. Kuoppa, G. Sandstrom, and A. Sjostedt. 1994. Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect. Immun. 62:178-183.
46. Evans, M. E. 1985. Francisella tularensis. Infect. Control 6:381-383.
47. Evans, M. E., D. W. Gregory, W. Schaffner, and Z. A. McGee. 1985. Tularemia: a 30 year experience with 88 cases. Medicine (Baltimore) 64:251-269.
48. Farlow, J., K. L. Smith, J. Wong, M. Abrams, M. Lytle, and P. Keim. 2001. Francisella tularensis strain typing using multiple-locus, variable number tandem repeat analysis. J. Clin. Microbiol. 39:3186-3192.
49. Forsman, M., E. W. Henningson, E. Larsson, T. Johansson, and G. Sandstrom. 2000. Francisella tularensis does not manifest virulence in viable but nonculturable state. FEMS Microbiol. Ecol. 31:217-224.
50. Forsman, M., G. Sandstrom, and A. Sjostedt. 1994. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int. J. Syst. Bacteriol. 44:38-46.
51. Fortier, A. H., T. Polsinelli, S. J. Green, and C. A. Nacy. 1992. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells and effector molecules. Infect. Immun. 60:817-825.
52. Fortier, A. H., S. J. Green, T. Polsinelli, T. R. Jones, R. M. Crawford, D. A. Leiby, K. L. Elkins, M. S. Meltzer, and C. A. Nacy. 1994. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol. Ser. 60:349-361.
53. Fortier, A. H., D. A. Leiby, R. B. Narayanan, E. Asafoadjei, R. M. Crawford, C. A. Nacy, and M. S. Meltzer. 1995. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect. Immun. 63:1478-1483.
54. Foshay, L., W. H. Hesselbrock, H. J. Wittenberg, and A. H. Rodenberg. 1942. Vaccine prophylaxis against tularemia in man. Am. J. Public Health 32:1131-1145.
55. Foshay, L. 1946. A comparative study of the treatment of tularemia with immune serum, hyperimmune serum and streptomycin. Am. J. Med. 1:180-188.
56. Foshay, L. 1950. Tularemia. Annu. Rev. Microbiol. 4:313-330.
57. Fournie, J. J., and M. Bonneville. 1996. Stimulation of gamma-delta cells by phosphoantigens. Res. Immunol. 147:338-347.
58. Francis, E. 1927. Microscopic changes of tularemia in the tick Dermacentor andersoni and the bedbug Cimex lectularius. Public Health Rep. 42:2763-2772.
59. Fulop, M., R. Manchee, and R. W. Titball. 1995. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine 13:1220-1225.
60. Fulop, M., D. Leslie, and R. Titball. 1996. A rapid, highly sensitive method for the detection of Francisella tularensis in clinical samples using the polymerase chain reaction. Amer. J. Trop. Med. Hyg. 54:364-366.
61. Fulop, M., R. Manchee, and R. Titball. 1996. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence. FEMS Immunol. Med. Microbiol. 13:245-247.
62. Fulop, M., P. Mastroeni, M. Green, and R. W. Titball. 2001. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of F. tularensis. Vaccine 19:4465-4472.
63. Gese, E. M., R. D. Schultz, M. R. Johnson, E. S. Williams, R. L. Crabtree, and R. L. Ruff. 1997. Serological survey for diseases in free-ranging coyotes (Canis latrans) in Yellowstone National Park, Wyoming. J. Wildl. Dis. 33:47-56.
64. Gill, V., and B. A. Cunha. 1997. Tularemia pneumonia. Semin. Respir. Infect. 12:61-67.
65. Gilligan, P. H. 1995. Pseudomonas and Burkholderia, p. 509-519. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology Press, Washington, D.C.
66. Golovliov, I., G. Sandstrom, M. Ericsson, A. Sjostedt, and A. Tarnvik. 1995. Cytokine expression in the liver during the early phase of murine tularemia. Infect. Immun. 63:534-538.
67. Golovliov, I., M. Ericsson, L. Akerblom, G. Sandstrom, A. Tarnvik, and A. Sjostedt. 1995. Adjuvanticity of ISCOMS incorporating a T-cell reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine 13:261-267.
68. Golovliov, I., K. Kuoppa, A. Sjostedt, A. Tarnvik, and G. Sandstrom. 1996. Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol. Med. Microbiol. 13:239-244.
69. Golovliov, I., M. Ericsson, G. Sandstrom, A. Tarnvik, and A. Sjostedt. 1997. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect. Immun. 65:2183-2189.
70. Reference deleted.
71. Green, S. J., L. F. Scheller, M. A. Marletta, M. C. Seguin, F. W. Klotz, M. Slayter, B. J. Nelson, and C. A. Nacy. 1994. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol. Lett. 43:87-94.
72. Grunow, R., W. Splettstoesser, S. McDonald, C. Otterbein, T. O'Brien, C. Morgan, J. Aldrich, E. Hoffer, E. Finke, and H. Meyer. 2000. Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin. Diagn. Lab. Immunol. 7:86-90.
73. Gurjcova, D. 1997. Analysis of the incidence and routes of transmission of tularemia in Slovakia. Epidemiol. Mikrobiol. Immunol. 46:67-72.
74. Gurjcova, D. 1998. First isolation of Francisella tularensis subsp. tularensis in Europe. Eur. J. Epidemiol. 14:797-802.
75. Helvaci, S., S. Gedikoglu, H. Akalin, and H. B. Oral. 2000. Tularemia in Bursa, Turkey: 205 cases in ten years. Eur. J. Epidemiol. 16:271-276.
76. Hermanowska-Szpakowicz, T., and S. A. Pancewicz. 1996. The presence of antibodies against Francisella tularensis among inhabitants of North-Eastern Poland. Przegl. Epidemiol. 50:55-59.
77. Higgins, J. A., Z. Hubalek, J. Halouzka, K. L. Elkins, A. Sjostedt, M. Shipley, and M. S. Ibrahim. 2000. Detection of Francisella tularensis in infected mammals and vectors using a probe-based polymerase chain reaction. Am. J. Trop. Med. 62:310-318.
78. Hiromatsu, K., Y. Yoshikai, G. Matsuzaki, S. Ohga, K. Muramori, J. Bluestone, and K. Nomoto. 1992. A protective role of γδ T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175:49-56.
79. Hoel, T., O. Scheel, S. H. Nordahl, and T. Sandvik. 1991. Water- and airborne Francisella tularensis biovar palaearctica isolated from human blood. Infection 19:348-350.
80. Hollis, D. G., R. E. Weaver, A. G. Steigerwalt, J. D. Wenger, C. W. Moss, and D. J. Brenner. 1989. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J. Clin. Microbiol. 27:1601-1608.
81. Holm, S. E., A. Tarnvik, and G. Sandstrom. 1980. Antigenic composition of a vaccine strain of Francisella tularensis. Int. Arch. Allergy Appl. Immunol. 61:136-144.
82. Hornick, R. B., and H. T. Eigelsbach. 1966. Aerogenic immunization of man with live tularemia vaccine. Bacteriol. Rev. 30:532-538.
83. Hornick, R. B., A. T. Dawkins, H. T. Eigelsbach, and J. J. Tulis. 1966. Oral tularemia vaccine in man. Antimicrob. Agents Chemother. 6:11-14.
84. Hubalek, Z., W. Sixl, and J. Halouzka. 1998. Francisella tularensis in Dermacentor reticulatus ticks from the Czech Republic and Austria. Wien. Klin. Wochenschr. 110:909-910.
85. Ibrahim, A., P. Gerner-Smidt, and A. Sjostedt. 1996. Amplification and restriction endonuclease digestion of a large fragment of genes coding for rRNA as a rapid method for discrimination of closely related pathogenic bacteria. J. Clin. Microbiol. 34:2894-2896.
86. Ikaheimo, I., H. Syrjala, J. Karhukorpi, R. Schildt, and M. Koskela. 2000. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J. Antimicrob. Chemother. 46:287-290.
87. Johansson, A., L. Berglund, L. Gothefors, A. Sjostedt, and A. Tarnvik. 2000. Ciprofloxacin for treatment of tularemia in children. Pediatr. Infect. Dis. J. 19:449-453.
88. Johansson, A., L. Berglund, U. Eriksson, I. Goransson, R. Wollin, M. Forsman, A. Tarnvik, and A. Sjostedt. 2000. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J. Clin. Microbiol. 38:22-26.
89. Johansson, A., A. Ibrahim, I. Goransson, U. Eriksson, D. Gurjcova, J. E. Clarridge, and A. Sjostedt. 2000. Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J. Clin. Microbiol. 38:4180-4185.
90. Johansson, A., I. Goransson, P. Larsson, and A. Sjostedt. 2001. Extensive allelic variation among Francisella tularensis strains in a short-sequence tandem repeat region. J. Clin. Microbiol. 39:3140-3146.
91. Junhui, Z., Y. Ruifu, L. Jianchun, Z. Songle, C. Meiling, C. Fengxiang, and C. Hong. 1996. Detection of Francisella tularensis by the polymerase chain reaction. J. Med. Microbiol. 45:477-482.
92. Kadull, P. J., H. R. Reames, L. L. Coriell, and L. Foshay. 1950. Studies on tularemia. V. Immunization of man. J. Immunol. 65:425-435.
93. Karhukorpi, E. K., and J. Karhukorpi. 2001. Rapid laboratory diagnosis of ulceroglandular tularemia with polymerase chain reaction. Scand. J. Infect. Dis. 33:383-385.
94. Karlsson, J., R. G. Prior, K. Williams, L. Lindler, K. A. Brown, N. Chatwell, K. Hjalmarsson, N. Loman, K. A. Mack, M. Pallen, M. Popek, G. Sandstom, A. Sjostedt, T. Svensson, I. Tamas, S. G. E. Andersson, B. W. Wren, P. C. F. Oyston, and R. W. Titball. 2000. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. Microbiol. Comp. Gen. 5:25-39.
95. Khatenever, L. M. 1943. The allergic diagnosis, specific prophylaxis and vaccine therapy of tularemia. p. 62-79. In E. B. Balsky, I. G. Kochergin, and V. V. Porin (ed.), Microbiology and epidemiology. Medical Publications Ltd., London, United Kingdom.
96. Koskela, P., and A. Salminen. 1985. Humoral immunity against Francisella tularensis after natural infection. J. Clin. Microbiol. 22:973-979.
97. Kostiala, A. A. I., D. D. McGregor, and P. S. Logie. 1975. Tularemia in the rat. I. The cellular basis of host resistance to infection. Immunology 28:855-869.
98. Kovarova, H., L. Hernychova, M. Hajduch, M. Sirova, and A. Macela. 2000. Influence of the Bcg locus on natural resistance to primary infection with the facultative intraccllular bacterium Francisella tularensis in mice. Infect. Immun. 68:1480-1484.
99. Kroca, M., A. Tarnvik, and A. Sjostedt. 2000. The proportion of circulating gamma delta T cells increases after the first week of onset of tularemia and remains elevated for more than one year. Clin. Exp. Immunol. 120:280-284.
100. Kudelina, R. I., and N. G. Olfsufjev. 1980. Sensitivity to macrolide antibiotics and lincomycin in Francisella holarctica. J. Hyg. Epidemiol. Microbiol. Immunol. 24:84-91.
101. Kupper, T. S. 1990. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J. Investig. Dermatol. 94:1465-1505.
102. Kwaik, Y. A., B. I. Eisenstein, and N. C. Engelberg. 1993. Phenotypic modification by Legionella pneumophila upon infection of macrophages. Infect. Immun. 61:1320-1329.
103. Labayru, C., A. Palop, L. Lopez-Urrutia, C. Avellaneda, M. A. Mazon, A. Alberte, and P. P. Pascual. 1999. Francisella tularensis: update on microbiological diagnosis after epidemic outbreak. Enferm. Infecc. Microbiol. Clin. 17:458-462.
104. Lai, X. H., I. Golovliov, and A. Sjostedt. 2001. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect. Immun. 69:4691-4694.
105. Lee, B. Y., and M. A. Horonitz. 1995. Identification of macrophage and stress-induced proteins by Mycobacterium tuberculosis. J. Clin. Investig. 96:245-249.
106. Leighton, F. A., U. A. Artsob, M. C. Chu, and J. G. Olson. 2001. A serological survey of rural dogs and cats on the southwestern Canadian prairie for zoonotic pathogens. Can. J. Public Health 92:67-71.
107. Lepitzki, D. A., A. Woolf, and M. Cooper. 1990. Serological prevalence of tularemia in cottontail rabbits of southern Illinois. J. Wildl. Dis. 26:279-282.
108. Levesque, B., G. de Serres, R. Higgins, M. A. D'Halewyn, H. Artsob, J. Grondin, M. Major, M. Garvie, and B. Duval. 1995. Seroepidemiologic study of three zoonoses (leptospirosis, Q fever and tularemia) among trappers in Quebec, Canada. Clin. Diagn. Lab. Immunol. 2:496-498.
109. Limaye, A. P., and C. J. Hooper. 1999. Treatment of tularemia with fluoroquinolones: two cases and review. Clin. Infect. Dis. 29:922-924.
110. Lofgren, S., A. Tarnvik, G. D. Bloom, and W. Sjoberg. 1983. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect. Immun. 39:715-720.
111. Lofgren, S., T. A., M. Thore, and J. Carlsson. 1984. A wild and susceptible strain of Francisella tularensis differs in susceptibility to hypochlorous acid: a possible explanation to their different handling by polymorphonuclear leukocytes. Infect. Immun. 43:730-734.
112. Malo, D., K. Vogan, S. Vidal, J. Hu, M. Cellier, E. Schurr, A. Fuks, N. Bumstead, K. Morgan, and P. Gros. 1994. Halotype mapping and sequence analysis of the mouse Nramp gene predicts susceptibility to infection with intracellular parasites. Genomics 23:51-61.
113. Mangold, T., and J. Goldberg. 1999. Plague wars: a true story of biological warfare. Macmillan Publishers Ltd., London, United Kingdom.
114. Maurin, M., N. F. Mersali, and D. Raoult. 2000. Bactericidal activities of antibiotics against intracellular Francisella tularensis. Antimicrob. Agents Chemother. 44:3428-3431.
115. McCoy, G. W., and C. W. Chapin. 1912. Further observations on a plague-like disease of rodents with a preliminary note on the causative agent, Bacterium tularense. J. Infect. Dis. 10:61-72.
116. McCrumb, F. R. 1961. Aerosol infection of man with Pasteurella tularensis. Bacteriol. Rev. 25:262-267.
117. McDonald, M. K., S. C. Cowley, and F. E. Nano. 1997. Temperature- sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature. J. Bacteriol. 179:7638-7643.
118. Mdluli, K. E., L. S. Anthony, G. S. Baron, M. K. McDonald, S. V. Mjltseva, and F. E. Nano. 1994. Serum sensitive mutation off. novicida: association with an ABC transporter gene. Microbiology 140:3309-3318.
119. Merriott, J., A. Shoemaker, and C. M. Downs. 1961. Growth of Pasteurella tularense in cultured cells. J. Infect. Dis. 108:136-150.
120. Montejo, M., J. Perez-Irezabal, P. G. de Zarate, K. Aguirrebengoa, J. M. Vicente, E. Martinez, S. Ibarra, E. Bereciartua, and C. Castell. 1998. Tularemia: report of 16 cases in the Castilla-Leon Community. Rev. Clin. Esp. 198:794-798.
121. Morner, T., and K. Sandstedt. 1983. A serological survey of antibodies against Francisella tularensis in some Swedish mammals. Nord. Vet. Med. 35:82-85.
122. Morner, T. 1992. The ecology of tularemia. Rev. Sci. Tech. Off. Int. Epiz. 11:1123-1130.
123. Morner, T., R. Mattsson, M. Forsman, K. E. Johansson, and G. Sandstrom. 1993. Identification and classification of different isolates of Francisella tularensis. Zentralbl. Veterinarmed B 40:613-620.
124. Niebjlski, M. L., M. G. Peacock, E. R. Fischer, S. F. Porcella, and T. G. Schwan. 1997. Characterization of an endosymbiont infecting wood ticks, Dermacentor andersoni, as a member of the genus Francisella. Appl. Environ. Microbiol. 63:3933-3940.
125. Noda, H., U. G. Munderloh, and T. J. Kurtti. 1997. Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals. Appl. Environ. Microbiol. 63:3926-3932.
126. Ohara, Y., T. Sato, H. Fujita, T. Ueno, and M. Homma. 1991. Clinical manifestations of tularemia in Japan-analysis of 1355 cases observed between 1924 and 1987. Infection 19:14-17.
127. Ohara, Y., T. Sato, and M. Homma. 1998. Arthropod-borne tularemia in Japan: clinical analysis of 1374 cases observed between 1924 and 1996. J. Med. Entomol. 35:471-473.
128. Olsufjev, N. G., O. S. Emelyanova, and T. N. Dunaeva. 1959. Comparative study of strains of B. tularense in the Old and New World and their taxonomy. J. Hyg. Epidemiol. Microbiol. Immunol. 3:138-149.
129. Olsufjev, N. G. 1970. Taxonomy and characteristic of the genus Francisella Dorofeev, 1947. J. Hyg. Epidemiol. Microbiol. Immunol. 14:67-74.
130. Olsufjev, N. G., and I. S. Meshcheryakova. 1983. Subspecific taxonomy of Francisella tularensis McCoy and Chapin 1912. Int. J. Syst. Bacteriol. 33:872-874.
131. Owen, C. R. 1974. Genus Francisella, p. 283-285. In R. E. Buchanan and N. E. Gibbons (ed.), Bergey's manual of determinative bacteriology. The Williams and Wilkins Co., Baltimore, Md.
132. Pavlov, V. M., A. N. Mokrievich, and K. Volkovoy. 1996. Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. FEMS Immunol. Med. Microbiol. 13:253-256.
133. Pavlovich, N. V., N. I. Shimaniuk, and B. N. Mishan'kin. 1992. Neuraminidase activity in representatives of the genus Francisella. Zh. Mikrobiol. Epidemiol. Immunobiol. 9-10:8-10.
134. Perez-Castrillon, J. L., P. Bachiller-Luque, M. Martin-Luquero, F. J. Mena-Martin, and V. Herreros. 2001. Tularemia epidemic in northwestern Spain: Clinical description and therapeutic response. Clin. Infect. Dis. 33:573-576.
135. Pollitzer, R. 1967. History and incidence of tularemia in the Soviet Union. A review. The Institute of Contemporary Russian Studies, Fordham University, New York, N.Y.
136. Polsinelli, T., M. S. Meltzer, and A. H. Fortier. 1994. Nitric oxide-independent killing of Francisella tularensis by IFN-γ-stimulated murine alveolar macrophages. J. Immunol. 153:1238-1245.
137. Poquet, Y., M. Kroca, F. Halary, S. Stenmark, M. Peyrat, M. Bonneville, J. J. Fournie, and A. Sjostedt. 1998. Expansion of Vγ9Vδ2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect. Immun. 66:2107-2114.
138. Prior, R. G., L. Klasson, P. Larsson, K. Williams, L. Lindler, A. Sjostedt, T. Svensson, I. Tamas, B. W. Wren, P. C. F. Oyston, S. G. E. Andersson, and R. W. Titball. 2001. Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. J. Appl. Microbiol. 91:1-7.
139. Provenza, J. M., S. A. Klotz, and R. L. Penn. 1986. Isolation of Francisella tularensis from blood. J. Clin. Microbiol. 24:453-455.
140. Puente-Redondo, V. A. de la, N. Garcia del Blanco, C. B. Gutierrez-Martin, F. J. Garcia-Pena, and, E. F. Rodriguez Ferri. 2000. Comparison of different PCR approaches for typing of Francisella tularensis strains. J. Clin. Microbiol. 38:1016-1022.
141. Reary, B. W., and S. A. Klotz. 1988. Enhancing recovery of Francisella tularensis from blood. Diagn. Microbiol. Infect. Dis. 11:117-119.
142. Reilly, T. J., G. S. Baron, F. E. Nano, and M. S. Kuhlenschmidt. 1996. Characterization and sequencing of a respiratory burst-inhibiting acid phos phatase from Francisella tularensis. J. Biol. Chem. 271:10973-10983.
143. Reintjes, R., I. Dedushaj, A. Gjini, T. R. Jorgensen, B. Cotter, A. Lieftucht, F. D'Ancona, D. T. Dennis, M. A. Kosoy, G. Mulliqi-Osmani, R. Grunow, A. Kalaveshi, L. Gashi, and I. Humolli. 2002. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg. Infect. Dis. 8:69-73.
144. Remaley, A. T., C. Das, P. I. Campbell, G. M. LaRocca, M. T. Pope, and R. H. Glew. 1985. Characterisation of Leishmania donovani acid phosphatases. J. Biol. Chem. 260:880-886.
145. Risi, G. F., and D. J. Pombo. 1995. Relapse of tularemia after aminoglycoside therapy-case-report and discussion of therapeutic options. Clin. Infect. Dis. 20:174-175.
146. Rodionova, I. V. 1967. Respiration of geographic variants of Francisella tularensis in the presence of glycerin. Zh. Mikrobiol. Epidemiol. Immunobiol. 44:21-25.
147. Russell, P., S. M. Eley, M. J. Fulop, D. L. Bell, and R. W. Titball. 1998. The efficacy of ciprofloxacin and doxycycline against experimental tularemia. J. Antimicrob. Chemother. 41:461-465.
148. Saha, A. K., J. N. Dowling, K. L. LaMarco, S. Das, A. T. Remaley, N. Olomu, M. T. Pope, and R. H. Glew. 1985. Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils. Arch. Biochem. Biophys. 243:150-160.
149. Sandstrom, G., and A. Tarnvik. 1987. Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J. Clin. Microbiol. 25:641-644.
150. Sandstrom, G., S. Lofgren, and A. Tarnvik. 1988. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56:1194-1202.
151. Sandstrom, G., A. Sjostedt, M. Forsman, N. V. Pavlovich, and B. N. Mishan'kin. 1992. Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan. J. Clin. Microbiol. 30:172-175.
152. Sandstrom, G., A. Sjostedt, T. Johansson, K. Kuoppa, and J. C. Williams. 1992. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 5:201-210.
153. Sandstrom, G. 1994. The tularemia vaccine. J. Chem. Tech. Biotech. 59:315-320.
154. Saslaw, S., H. T. Eigelsbach, J. A. Prior, H. E. Wilson, and S. Carhart. 1961. Tularemia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107:702-714.
155. Saslaw, S., H. T. Eigelsbach, H. E. Wilson, J. A. Prior, and S. Carhart. 1961. Tularemia vaccine study. I. Intracutaneous challenge. Arch. Intern. Med. 107:689-701.
156. Shepard, C. C. 1959. Non-acid-fast bacteria and HeLa cells: their uptake and subsequent intracellular growth. J. Bacteriol. 77:701-714.
157. Sjostedt, A., G. Sandstrom, and A. Tarnvik. 1990. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturallly infected individuals. J. Clin. Microbiol. 28:43-48.
158. Sjostedt, A., G. Sandstrom, and A. Tarnvik. 1990. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. Res. Microbiol. 141:887-891.
159. Sjostedt, A., G. Sandstrom, and A. Tarnvik. 1992. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect. Immun. 60:2855-2862.
160. Sjostedt, A., A. Tarnvik, and G. Sandstrom. 1996. Francisella tularensis: host-parasite interaction. FEMS Immunol. Med. Microbiol. 13:181-184.
161. Sjostedt, A., J. W. Conlan, and R. J. North. 1994. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62:2779-2783.
162. Sjostedt, A., U. Eriksson, L. Berglund, and A. Tarnvik. 1997. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J. Clin. Microbiol. 35:1045-1048.
163. Skrodzki, E. 1968. Investigations on the pathogenesis of tularemia. VII. Attempts to discover F. tularensis toxins. Biol. Inst. Med. Morsk. Gdansk 19:69-76.
164. Sorokin, V. M., N. V. Parlovich, and L. A. Prozorova. 1996. Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol. Med. Microbiol. 13:249-252.
165. Steinemann, T. L., M. R. Sheikholeslami, H. H. Brown, and R. W. Bradsher. 1999. Oculoglandular tularemia. Arch. Opthalmol. 117:132-133.
166. Stewart, S. J. 1996. Tularemia: association with hunting and farming. FEMS Immunol. Med. Microbiol. 13:197-199.
167. Stulik, J., L. Hernychova, A., Macela, Z. Krocova, and M. Kroca. 1999. Production of stress-inducible form of heat-shock protein 70 in mouse peritoneal adherent cells after in vivo infection by Francisella tularensis. Folia Microbiol. (Prague) 44:306-310.
168. Sumida, T., T. Maeda, H. Takahashi, S. Yoshida, F. Yonaha, A. Sakamoto, H. Tomioka, T. Koike, and S. Yoshida. 1992. Predominant expansion of V γ9/Vδ2 T cells in a tularemia patient. Infect. Immun. 60:2554-2558.
169. Surcel, H. M., M. Sanas, I. M. Helander, and E. Herva. 1989. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microb. Pathog. 7:411-419.
170. Syrjala, H., P. Kujala, V. Myllyla, and A. Salminen. 1985. Airborne transmission of tularemia in farmers. Scand. J. Infect. Dis. 17:371-375.
171. Syrjala, H., P. Koskela, T. Ripatti, A. Salminen, and E. Herva. 1986. Agglutination and ELISA methods in the diagnosis of tularemia in different clinical severities of the disease. J. Infect. Dis. 153:142-145.
172. Tarnvik, A., S. Lofgren, L. Ohlund, and G. Sandstrom. 1987. Detection of antigen in urine of a patient with tularemia. Eur. J. Clin. Microbiol. 6:318-319.
173. Tarnvik, A. 1989. Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11:440-451.
174. Tarnvik, A., C. Henning, E. Falsen, and G. Sandstrom. 1989. Isolation of Francisella tularensis biovar palaeartica from human blood. Eur. J. Clin. Microbiol. Infect. Dis. 8:146-150.
175. Tarnvik, A., G. Sandstrom, and A. Sjostedt. 1996. Epidemiological analysis of tularemia in Sweden, 1931-1993. FEMS Immunol. Med. Microbiol. 13:201-204.
176. Tarnvik, A., M. Ericsson, I. Golovliov, G. Sandstrom, and A. Sjostedt. 1996. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol. Med. Microbiol. 13:221-225.
177. Thompson, S., L. Omphroy, and T. Oetting. 2001. Parinaud's oculoglandular syndrome attributable to an encounter with a wild rabbit. Am. J. Ophthalmol. 131:283-284.
178. Tigertt, W. D. 1962. Soviet viable Pasteurella tularensis vaccines: a review of selected articles. Bacteriol. Rev. 26:354-373.
179. Waag, D. M., G. Sandstrom, M. J. England, and J. C. Williams. 1996. Immunogenicity of a new lot of Francisella tularemis live vaccine strain in human volunteers. FEMS Immunol. Med. Microbiol. 13:205-209.
180. Wenger, J. D., D. G. Hollis, R. E. Weaver, C. N. Baker, G. R. Brown, D. J. Brenner, and C. V. Broome. 1989. Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognised human pathogen. Ann. Intern. Med. 110:888-892.
181. Westerman, E. L., and J. McDonald. 1983. Tularemia pnuemonia mimicking Legionnaires' disease: isolation of organism on CYE agar and successful treatment with erythromycin. South. Med. J. 76:1169-1170.
182. Wherry, J. C., R. D. Schreiber, and E. R. Unanue. 1991. Regulation of gamma interferon production by natural killer cells in SCID mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709-1715.
183. Wicki, R., P. Sauter, C. Mettler, A. Natsch, T. Enzler, N. Pusterla, P. Kuhnert, G. Egli, M. Bernasconi, R. Lienhard, H. Lutz, and C. M. Leutenegger. 2000. Swiss Army survey in Switzerland to determine the prevalence of Francisella tularensis, members of the Ehrlichia phagocytophila genogroup, Borrelia burgdorferi sensu lato, and tick-borne encephalitis virus in ticks. Eur. J. Clin. Microbiol. Infect. Dis. 19:427-432.
184. Wilson, G. S., and A. A. Miles. 1964. Brucella tularensis, p. 1013-1014 In Topley and Wilson's principles of bacteriology and immunity. The Williams and Wilkins Co., Baltimore. Md.
185. Yee, D., T. R. Rhinehart-Jones, and K. L. Elkins. 1996. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen. Francisella tularensis strain LVS. J. Immunol. 157:5042-5048.